Biography

• Ji-Guang Wang is director of the Shanghai Institute of Hypertension, and director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

• At present, he is coordinating several multicentre randomized clinical trials and population- and patient-cohort studies in China. He has published 544 full-length articles on hypertension in the international literature and 186 articles in the Chinese literature, and has lectured extensively in international and China national conferences.

• He is a former Executive Council Member of the International Society of Hypertension, past president of the Asian-Pacific Society of Hypertension, past president of the Pulse of Asia Society, current deputy president of the HOPE Asia Network, and current president of the Chinese Hypertension League.

• He serves on the editorial board of several international and China national journals in the field of hypertension and cardiovascular medicine as Editor-in-Chief, Associate Editor, Section Editor or a Member.

• Keywords: hypertension, blood pressure, epidemiology, clinical trial

Publications

1. Zhang DY, Huang JF, Kang YY, Dou Y, Su YL, Zhang LJ, Cheng YB, Guo QH, Huang QF, Li Y, Wang JG. The prevalence of masked hypertension in relation to cigarette smoking in a Chinese male population. Journal of Hypertension 2020; 38(6):1056-1063. doi: 10.1097/HJH.0000000000002392.

2. Chen Y, Huang QF, Sheng CS, Zhang W, Shao S, Wang D, Cheng YB, Wang Y, Guo QH, Zhang DY, Li Y, Lowres N, Freedman B, Wang JG. Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): a prospective multicenter study. PLOS Medicine 2020; 17(7):e1003146. doi: 10.1371/journal.pmed.1003146.

3. Ye XF, Miao CY, Zhang W, Sheng CS, Huang QF, Wang JG. Alcohol consumption in relation to cardiovascular and non-cardiovascular mortality in an elderly male Chinese population. BMC Public Health. 2021; 21(1):2053. doi: 10.1186/s12889-021-12140-6.

4. Zhang D, Huang QF, Li Y, Wang JG. A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension. Hypertens Research. 2021; 44(5):533-540. doi: 10.1038/s41440-020-00602-0.

5. Huang QF, Cheng YB, Guo QH, Liu CY, Kang YY, Sheng CS, Li Y, Wang JG. Clinic and ambulatory blood pressure in relation to the interaction between plasma advanced glycation end products and sodium dietary intake and renal handling. Hypertens Res. 2022; 45(4):665-674. doi: 10.1038/s41440-021-00805-z.